Pentokey Organy (India) Analysis

dividend

Pros

Cons

• Unable to calculate sustainability of dividends as Pentokey Organy (India) has not reported any payouts.
• Unable to evaluate Pentokey Organy (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Pentokey Organy (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Pentokey Organy (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Pentokey Organy (India) has no debt, it does not need to be covered by operating cash flow.
• Pentokey Organy (India) has no debt, it does not need to be covered by short term assets.
• Pentokey Organy (India)'s cash and other short term assets cover its long term commitments.
• Pentokey Organy (India) has no debt compared to 5 years ago when it was 365.4%.
• Pentokey Organy (India) has no debt, therefore coverage of interest payments is not a concern.
• Pentokey Organy (India) has no debt.
• Low level of unsold assets.

Cons

management

Pros

• The tenure for the Pentokey Organy (India) board of directors is about average.
• M. N.'s remuneration is lower than average for companies of similar size in India.
• The tenure for the Pentokey Organy (India) management team is about average.

Cons

• M. N.'s compensation has increased whilst company is loss making.

misc

Pros

Cons

• Pentokey Organy (India) is not covered by any analysts.

past

Pros

Cons

• Unable to compare Pentokey Organy (India)'s 1-year earnings growth to the 5-year average as it is not currently profitable.
• Pentokey Organy (India) does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
• It is difficult to establish if Pentokey Organy (India) has efficiently used its assets last year compared to the IN Trade Distributors industry average (Return on Assets) as it is loss-making.
• It is difficult to establish if Pentokey Organy (India) improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
• It is difficult to establish if Pentokey Organy (India) has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
• Unable to compare Pentokey Organy (India)'s 1-year growth to the IN Trade Distributors industry average as it is not currently profitable.

value

Pros

Cons

• Pentokey Organy (India) is overvalued based on assets compared to the IN Trade Distributors industry average.
• Pentokey Organy (India) is loss making, we can't compare its value to the IN Trade Distributors industry average.
• Pentokey Organy (India) is loss making, we can't compare the value of its earnings to the India market.
• 524210 underperformed the Trade Distributors industry which returned -5.6% over the past year.
• 524210 underperformed the Market in India which returned -14.5% over the past year.
• BSE:524210 is down -9.7% underperforming the Trade Distributors industry which returned 6.8% over the past month.
• BSE:524210 is down -9.7% underperforming the market in India which returned 8% over the past month.